Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
TGAN

Transphorm Inc

TGAN

Market Closed
Watchlist

TGAN RSI Chart

TGAN Valuation

Market Cap

182.2M

Price/Earnings (Trailing)

-5.39

Price/Sales (Trailing)

9.81

Price/Free Cashflow

-11.75

TGAN Price/Sales (Trailing)

TGAN Profitability

Operating Margin

4.13%

Return on Equity

-142.79%

Return on Assets

-98.66%

Free Cashflow Yield

-8.51%

TGAN Fundamentals

TGAN Revenue

Revenue (TTM)

18.6M

Revenue Y/Y

36.51%

Revenue Q/Q

-14.84%

TGAN Earnings

Earnings (TTM)

-33.8M

Earnings Y/Y

-18.92%

Earnings Q/Q

4.27%

Price Action

Last 7 days

-3.3%

Last 30 days

10.1%

TGAN Financial Health

Current Ratio

2.63

TGAN Investor Care

Shares Dilution (1Y)

9.46%

Diluted EPS (TTM)

-0.68

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202316.5M17.2M18.6M0
202224.1M26.0M18.4M18.2M
202112.7M9.6M19.0M21.5M
202012.5M18.3M19.3M11.3M
20194.0M6.7M9.3M11.9M
20180001.4M

Latest Insider Trading transactions for TGAN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 22, 2023
smales kelly
sold
-10,498
2.628
-3,995
-
Nov 22, 2023
mcfarland katharina g.
sold
-10,798
2.703
-3,995
-
Nov 20, 2023
smales kelly
sold
-1,894
2.888
-656
-
Nov 20, 2023
mcfarland katharina g.
sold
-10,580
3.01
-3,515
-
Nov 17, 2023
parikh primit
sold (taxes)
-22,351
2.77
-8,069
president and ceo
Nov 17, 2023
smales kelly
sold
-9,093
2.818
-3,227
-
Nov 17, 2023
mcaulay cameron
sold (taxes)
-7,024
2.77
-2,536
chief financial officer
Nov 17, 2023
mishra umesh
sold (taxes)
-4,470
2.77
-1,614
chief technology officer
Oct 20, 2023
moreland cynthia j
acquired
-
-
2,083
-
Oct 20, 2023
smales kelly
acquired
-
-
2,708
-

1–10 of 50

Which funds bought or sold TGAN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-99.84
-27,338
29.00
-%
Nov 24, 2023
DEUTSCHE BANK AG\
reduced
-95.81
-61,573
1,732
-%
Nov 21, 2023
Alpine Global Management, LLC
sold off
-100
-250,580
-
-%
Nov 15, 2023
MORGAN STANLEY
added
35.08
-9,137
68,321
-%
Nov 15, 2023
Worth Venture Partners, LLC
added
4.59
-1,187,660
2,558,060
1.52%
Nov 14, 2023
Kohlberg Kravis Roberts & Co. L.P.
unchanged
-
-26,757,700
50,340,700
1.77%
Nov 14, 2023
SOROS FUND MANAGEMENT LLC
reduced
-20.93
-707,200
754,800
0.01%
Nov 14, 2023
JPMORGAN CHASE & CO
reduced
-85.64
-376,039
38,901
-%
Nov 14, 2023
Royal Bank of Canada
added
109
2,000
8,000
-%
Nov 14, 2023
VANGUARD GROUP INC
added
6.86
-1,408,730
3,251,950
-%

1–10 of 45

Latest Funds Activity

Are funds buying TGAN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TGAN
No. of Funds

Recent SEC filings of Transphorm Inc

View All Filings
Date Filed Form Type Document
Nov 27, 2023
144/A
144/A
Nov 27, 2023
144/A
144/A
Nov 27, 2023
144/A
144/A
Nov 27, 2023
144/A
144/A
Nov 27, 2023
144/A
144/A
Nov 27, 2023
4
Insider Trading
Nov 27, 2023
4
Insider Trading
Nov 21, 2023
4
Insider Trading
Nov 21, 2023
4
Insider Trading
Nov 21, 2023
4
Insider Trading

Peers (Alternatives to Transphorm Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.2T
44.9B
2.01% 176.71%
62.2
26.18
57.07% 217.10%
208.2B
22.1B
13.51% 82.97%
1.0K
9.42
-3.14% -90.85%
180.0B
52.9B
12.61% 51.97%
-109.5
3.41
-23.98% -112.36%
123.8B
26.5B
2.42% 36.33%
19.21
4.66
5.50% -3.05%
91.7B
12.3B
9.45% 9.48%
27.68
7.46
2.43% 20.59%
MID-CAP
7.1B
6.7B
23.06% 6.76%
17.39
1.06
-3.65% -50.30%
4.3B
1.8B
9.02% 1.07%
30.6
2.45
-10.70% -59.88%
4.0B
1.1B
-5.85% 49.75%
17.32
3.7
26.38% 43.48%
3.3B
1.8B
7.92% -18.08%
11.26
1.8
-7.52% -3.55%
2.3B
290.7M
16.64% -27.14%
-23.52
7.93
-17.79% -146.17%
SMALL-CAP
958.4M
495.9M
-9.50% 77.78%
13.41
1.93
32.10% 66.11%
744.7M
74.9M
9.06% 1.17%
39.95
9.94
34.12% 99.53%
630.4M
663.5M
7.12% -29.81%
-79.92
0.95
-16.96% -101.73%
181.5M
-
33.84% -2.49%
-9.32
576.4
-4.50% -12.39%
92.2M
117.9M
-5.48% -25.65%
25.5
0.78
19.93% -73.89%

Transphorm Inc News

Latest updates
Marketscreener.com30 Nov 202301:32 pm9 days ago
Stockhouse Publishing09 Nov 202308:00 am30 days ago
Yahoo Finance08 Nov 202308:00 am31 days ago
Business Wire India07 Nov 202308:00 am32 days ago
Yahoo Finance25 Oct 202307:00 am45 days ago
Insider Monkey03 Oct 202307:00 am2 months ago
Yahoo Finance24 Aug 202307:00 am3 months ago
Barchart14 Aug 202307:00 am3 months ago
Seeking Alpha11 Aug 202307:00 am4 months ago
Yahoo Finance09 Aug 202307:00 am4 months ago
Yahoo Finance06 Jul 202307:00 am5 months ago
Yahoo Finance29 May 202307:00 am6 months ago
Simply Wall St17 May 202307:00 am6 months ago
Yahoo Finance02 May 202307:00 am7 months ago
Seeking Alpha28 Jul 202207:00 am16 months ago

Financials for Transphorm Inc

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-14.8%5,010,0005,883,0003,192,0004,493,0003,670,0005,156,0004,927,0004,604,00011,303,0003,216,0002,425,0002,013,0001,929,0006,300,0001,100,0009,928,500994,000488,000529,000-
Cost Of Revenue1.1%3,836,0003,795,0003,017,0007,162,0003,232,0004,050,0003,789,0003,935,0002,239,0002,567,0001,788,0001,936,0002,043,0001,248,0001,455,0002,281,0001,625,0001,182,0001,404,000-
Gross Profit-43.8%1,174,0002,088,000175,000-2,669,000438,0001,106,0001,138,000669,0009,064,000649,000637,000---------
Costs and Expenses-13.5%7,672,0008,867,0008,518,0007,229,0005,940,0006,140,0005,596,0005,437,0005,130,0005,253,0005,176,0006,460,0006,349,0005,428,0006,531,0007,284,0005,508,0005,373,0005,688,000-
  S&GA Expenses15.2%1,708,0001,482,0001,651,0001,447,0001,066,0001,083,0001,047,000976,000825,000687,000663,000581,000547,000528,000518,000511,000572,000675,000851,00010,337
  R&D Expenses5.3%3,022,0002,869,0003,013,0002,325,0001,830,0001,740,0001,632,0001,609,0001,591,0001,823,0001,780,0001,453,0001,071,0001,594,0001,466,0001,901,0002,041,0002,022,0002,182,000-
Interest Expenses-100.0%-8,000180,000184,000184,000182,000181,000187,000220,000204,000187,000191,000191,000189,000189,000191,000191,000189,000187,000969
Income Taxes---------------------
Net Income4.3%-7,129,000-7,447,000-8,792,000-10,460,000-5,995,000-5,353,000-4,999,000-4,164,0005,980,000-7,052,000-6,579,000-4,712,000-6,740,000-2,270,000-4,187,0002,434,000-5,446,000-5,901,000-6,370,000-11,306
Net Income Margin4.0%-1.82-1.90-1.85-1.47-1.12-0.33-0.43-0.55-0.65-2.62-1.60-1.58-0.40-0.35-0.81-1.03-6.61-6.04-3.02-0.03
Free Cashflow46.5%-4,697,000-8,773,000-9,230,0007,193,000-8,190,000-5,636,000-5,731,000-5,579,000-3,892,000-5,129,000-5,097,000-1,434,000-3,205,000-3,383,000-6,151,000-62,285-40,389-1,173,000-5,434,000-98,900
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets1.7%34,28933,71544,45249,24557,95063,73048,64654,84214,33614,03418,14422,22612,86617,74323,15210,26210,32110,38110,44010,4997,001
  Current Assets8.0%21,92520,29530,68836,39946,64755,85444,79450,66110,1769,79314,29418,2268,60913,32118,5575,3571.002.003.004,8254.00
    Cash Equivalents85.8%6,1523,31115,52723,14933,49642,61333,43540,4671,9882,4629,50014,6944,3699,38214,6482,8752,9114,3982,5073,0694.00
  Inventory10.0%9,7768,8858,4067,4768,9666,9636,3305,9564,7742,9242,2231,6271,3721,3421,085990---852-
  Net PPE-1.3%7,8577,9577,8905,3675,3282,1991,6491,8971,7611,8321,3601,3241,4321,5331,6371,770---2,132-
  Goodwill-3.1%9639941,0791,0979961,0561,1801,2501,2861,3031,3021,3971,3621,3361,3261,325---1,306-
Liabilities-2.7%10,59810,89124,83721,06321,60521,79217,28518,62333,88245,03743,19942,08242,35441,09544,32146,85743,23839,61935,99932,38021,604
  Current Liabilities0.8%8,3398,27121,93718,39318,80218,8515,2856,62321,88215,84727,07126,69026,02725,51530,43620,68811710895.0016,52871.00
Shareholder's Equity3.8%23,69122,82419,61528,18236,34541,93831,36136,219-------------
  Retained Earnings-3.2%-229,424-222,295-209,236-200,446-189,986-183,991-178,638-173,639-169,475-175,455-168,403-161,824-157,112-150,372-148,102-143,915-140-130-117-128,632-91.48
  Additional Paid-In Capital3.3%255,249247,027230,272229,954228,178227,512211,190210,841150,843145,332144,201142,736128,385127,787127,68322,40425.0025.0025.0021,82925.00
Shares Outstanding4.4%61,98159,37457,04756,86256,62654,40553,37949,14841,19640,63740,53235,72035,15735,13631,9124,22128,15428,15428,1544,2202,308
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations53.2%-4,107-8,773-7,9278,800-4,887-4,913-5,826-5,298-3,829-4,783-4,933-1,422-3,181-3,361-6,151-490-1.39-565-5,351-15.90-45*
  Share Based Compensation-54.4%9132,0038571,123636583758848511497513705584104132131159137139--
Cashflow From Investing22.3%-590-759-2,054-2,639-4,052-1,401-666-965-1,126-2,364-1,132-2,033-1,924-1,901-1,548-1,050-632-1,030-189--
Cashflow From Financing367.6%7,654-2,8602,41165330.0015,740-40944,7735,00013495613,64614.00-19,4982,0004,0002,0085,000--

TGAN Income Statement

2023-09-30
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenue, net, including related parties (Note 11)$ 5,010$ 3,670$ 10,893$ 8,826
Cost of goods sold3,8363,2327,6317,282
Gross profit1,1744383,2621,544
Operating expenses:    
Research and development3,0221,8305,8913,570
Sales and marketing1,7081,0663,1902,149
General and administrative2,9423,0447,4586,361
Total operating expenses7,6725,94016,53912,080
Loss from operations(6,498)(5,502)(13,277)(10,536)
Interest expense01848366
Loss in joint venture7216841,5811,266
Other income, net(90)(375)(290)(820)
Loss before tax expense(7,129)(5,995)(14,576)(11,348)
Tax expense0000
Net loss(7,129)(5,995)(14,576)(11,348)
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)005,6120
Net loss attributable to common stockholders(7,129)(5,995)(20,188)(11,348)
Net loss attributable to common stockholders$ (7,129)$ (5,995)$ (20,188)$ (11,348)
Net loss per share - basic (in usd per share)$ (0.12)$ (0.10)$ (0.33)$ (0.20)
Net loss per share - diluted (in usd per share)$ (0.12)$ (0.10)$ (0.33)$ (0.20)
Weighted average common shares outstanding - basic (in shares)61,138,69156,619,66261,071,72955,518,297
Weighted average common shares outstanding - diluted (in shares)61,138,69156,619,66261,071,72955,518,297

TGAN Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Mar. 31, 2023
Current assets:  
Cash and cash equivalents$ 6,152$ 15,527
Restricted cash0500
Accounts receivable, net of allowance for doubtful accounts of $263 and $0 at September 30, 2023 and March 31, 2023, respectively, including related parties (Note 11)4,5714,396
Inventory9,7768,406
Prepaid expenses and other current assets1,4261,859
Total current assets21,92530,688
Property and equipment, net7,8577,890
Operating lease right-of-use assets2,7193,033
Goodwill9631,079
Intangible assets, net173321
Investment in joint venture0715
Other assets652726
Total assets34,28944,452
Current liabilities:  
Accounts payable and accrued expenses, including related parties (Note 11)6,1987,895
Accrued interest0180
Unfunded commitment in joint venture590
Accrued payroll and benefits1,5571,458
Operating lease liabilities525404
Revolving credit facility012,000
Total current liabilities8,33921,937
Operating lease liabilities, net of current portion2,2592,670
Other liabilities0230
Total liabilities10,59824,837
Commitments and contingencies (Note 7)
Stockholders’ equity:  
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and none issued and outstanding as of September 30, 2023 and March 31, 202300
Common stock, $0.0001 par value; 750,000,000 shares authorized as of September 30, 2023 and March 31, 2023, and 61,981,134 and 57,047,013 shares issued and outstanding as of September 30, 2023 and March 31, 2023, respectively66
Additional paid-in capital255,249230,272
Accumulated deficit(229,424)(209,236)
Accumulated other comprehensive loss(2,140)(1,427)
Total stockholders’ equity23,69119,615
Total liabilities and stockholders’ equity$ 34,289$ 44,452
TGAN
Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.
 CEO
 WEBSITEwww.transphormusa.com
 EMPLOYEES131

Transphorm Inc Frequently Asked Questions


What is the ticker symbol for Transphorm Inc? What does TGAN stand for in stocks?

TGAN is the stock ticker symbol of Transphorm Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Transphorm Inc (TGAN)?

As of Fri Dec 08 2023, market cap of Transphorm Inc is 182.22 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TGAN stock?

You can check TGAN's fair value in chart. The fair value of Transphorm Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Transphorm Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TGAN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Transphorm Inc a good stock to buy?

The fair value guage provides a quick view whether TGAN is over valued or under valued. Whether Transphorm Inc is cheap or expensive depends on the assumptions which impact Transphorm Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TGAN.

What is Transphorm Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, TGAN's PE ratio (Price to Earnings) is -5.39 and Price to Sales (PS) ratio is 9.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TGAN PE ratio will change depending on the future growth rate expectations of investors.